| Product Code: ETC11830149 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cell and Gene Supply Chain Services Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cell and Gene Supply Chain Services Market Revenues & Volume, 2021 & 2031F |
3.3 China Cell and Gene Supply Chain Services Market - Industry Life Cycle |
3.4 China Cell and Gene Supply Chain Services Market - Porter's Five Forces |
3.5 China Cell and Gene Supply Chain Services Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China Cell and Gene Supply Chain Services Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 China Cell and Gene Supply Chain Services Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 China Cell and Gene Supply Chain Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Cell and Gene Supply Chain Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in cell and gene therapy research and development in China |
4.2.2 Growing demand for personalized medicine and advanced therapeutics |
4.2.3 Favorable government initiatives and policies supporting the biotechnology sector in China |
4.3 Market Restraints |
4.3.1 Lack of standardized regulations and quality control measures in the cell and gene therapy supply chain |
4.3.2 High costs associated with developing and maintaining specialized infrastructure for cell and gene therapy services |
5 China Cell and Gene Supply Chain Services Market Trends |
6 China Cell and Gene Supply Chain Services Market, By Types |
6.1 China Cell and Gene Supply Chain Services Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Cryogenic Storage Solutions, 2021 - 2031F |
6.1.4 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Logistics and Distribution, 2021 - 2031F |
6.1.5 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Quality Control Services, 2021 - 2031F |
6.1.6 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Supply Chain Software, 2021 - 2031F |
6.2 China Cell and Gene Supply Chain Services Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Cold Chain Management, 2021 - 2031F |
6.2.3 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Real-time Monitoring, 2021 - 2031F |
6.2.4 China Cell and Gene Supply Chain Services Market Revenues & Volume, By AI-driven Analytics, 2021 - 2031F |
6.2.5 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Blockchain Integration, 2021 - 2031F |
6.3 China Cell and Gene Supply Chain Services Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Biopharmaceutical Firms, 2021 - 2031F |
6.3.3 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.3.4 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Hospitals and Clinics, 2021 - 2031F |
6.3.5 China Cell and Gene Supply Chain Services Market Revenues & Volume, By CDMO and CROs, 2021 - 2031F |
6.4 China Cell and Gene Supply Chain Services Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Safe Storage of Cell Therapies, 2021 - 2031F |
6.4.3 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Secure Transportation of Samples, 2021 - 2031F |
6.4.4 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Ensuring Regulatory Compliance, 2021 - 2031F |
6.4.5 China Cell and Gene Supply Chain Services Market Revenues & Volume, By Tracking and Data Transparency, 2021 - 2031F |
7 China Cell and Gene Supply Chain Services Market Import-Export Trade Statistics |
7.1 China Cell and Gene Supply Chain Services Market Export to Major Countries |
7.2 China Cell and Gene Supply Chain Services Market Imports from Major Countries |
8 China Cell and Gene Supply Chain Services Market Key Performance Indicators |
8.1 Average turnaround time for cell and gene therapy products in the supply chain |
8.2 Number of successful clinical trials utilizing cell and gene therapy services in China |
8.3 Rate of adoption of innovative technologies and automation in the supply chain for cell and gene therapy products |
9 China Cell and Gene Supply Chain Services Market - Opportunity Assessment |
9.1 China Cell and Gene Supply Chain Services Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China Cell and Gene Supply Chain Services Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 China Cell and Gene Supply Chain Services Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 China Cell and Gene Supply Chain Services Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Cell and Gene Supply Chain Services Market - Competitive Landscape |
10.1 China Cell and Gene Supply Chain Services Market Revenue Share, By Companies, 2024 |
10.2 China Cell and Gene Supply Chain Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here